Skip to main contentSkip to navigation
Sirius Investors
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUF
OTCHealthcare

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Investment Research Dashboard

About Hisamitsu Pharmaceutical Co., Inc. (HTSUF) stock analysis

Get live HTSUF stock price $29.00, comprehensive Hisamitsu Pharmaceutical Co., Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HTSUF stock data and investment insights.

29.00
0.00%Today
Market Cap
2.04B
Volume
100
52W High
32.30
52W Low
28.94

Loading chart data...

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Overview

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, HTSUF trades at $29.00 with a market capitalization of 2.04B . Over the past 52 weeks, HTSUF has traded between $28.94 and $32.30 , with the current price positioned at approximately 2% of...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 2.04B
  • Current price: $29.00
  • 52-week range: $28.94 - $32.30
  • P/E ratio: 16.45

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Hisamitsu Pharmaceutical Co., Inc. is a Japanese enterprise that develops and markets a range of pharmaceuticals, quasi-drugs, and medical devices. Its extensive product catalog includes popular external pain relief solutions such as SALONPAS, NOBINO...

Company Information

CEO
Kazuhide Nakatomi
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2759

Contact Information

Address
408, Tashiro Daikan-machi
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 16.5)

Lower volatility stock (Beta: 0.29) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Hisamitsu Pharmaceutical Co., Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Hisamitsu Pharmaceutical Co., Inc.
  • Investors should consider how Hisamitsu Pharmaceutical Co., Inc. fits within their overall portfolio allocation

Market Cap

2.04B

P/E Ratio (TTM)

16.45

Beta

0.29

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.